Literature DB >> 11821063

Lectin-like oxidized LDL receptor-1 (LOX-1) supports adhesion of mononuclear leukocytes and a monocyte-like cell line THP-1 cells under static and flow conditions.

Kazutaka Hayashida1, Noriaki Kume, Manabu Minami, Toru Kita.   

Abstract

Adhesion of mononuclear leukocytes to vascular endothelial cells appears one of the initial steps in the process of atherogenesis and inflammation. We examined if LOX-1, an endothelial scavenger receptor with C-type lectin-like structure, can support adhesion of mononuclear leukocytes. Under a static condition, CHO-K1 cells stably expressing LOX-1 showed more prominent adhesion of human peripheral blood mononuclear leukocytes and THP-1 cells than untransfected CHO-K1 cells, in a temperature-independent fashion. Mononuclear leukocytes also adhered to plastic plates precoated with recombinant soluble LOX-1 extracellular domain. A neutralizing anti-LOX-1 monoclonal antibody, as well as oxidized low-density lipoprotein, significantly blocked adhesion of THP-1 cells to CHO-K1 cells overexpressing LOX-1 and bovine aortic endothelial cells. Under a flow condition, increased numbers of THP-1 cells showed rolling with reduced velocities on LOX-1-expressing CHO-K1 cells, compared with those on untransfected CHO-K1 cells. Taken together, LOX-1 can work as a cell surface receptor for mononuclear leukocytes under both static and flow conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821063     DOI: 10.1016/s0014-5793(01)03297-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Exploring the genetic signature of body size in Yucatan miniature pig.

Authors:  Hyeongmin Kim; Ki Duk Song; Hyeon Jeong Kim; WonCheoul Park; Jaemin Kim; Taeheon Lee; Dong-Hyun Shin; Woori Kwak; Young-jun Kwon; Samsun Sung; Sunjin Moon; Kyung-Tai Lee; Namshin Kim; Joon Ki Hong; Kyung Yeon Eo; Kang Seok Seo; Girak Kim; Sungmoo Park; Cheol-Heui Yun; Hyunil Kim; Kimyung Choi; Jiho Kim; Woon Kyu Lee; Duk-Kyung Kim; Jae-Don Oh; Eui-Soo Kim; Seoae Cho; Hak-Kyo Lee; Tae-Hun Kim; Heebal Kim
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

Review 2.  More Than Just a Removal Service: Scavenger Receptors in Leukocyte Trafficking.

Authors:  Daniel A Patten; Shishir Shetty
Journal:  Front Immunol       Date:  2018-12-12       Impact factor: 7.561

3.  Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD.

Authors:  Joshua W Knowles; Themistocles L Assimes; Eric Boerwinkle; Stephen P Fortmann; Alan Go; Megan L Grove; Mark Hlatky; Carlos Iribarren; Jun Li; Richard Myers; Neil Risch; Stephen Sidney; Audrey Southwick; Kelly A Volcik; Thomas Quertermous
Journal:  BMC Med Genet       Date:  2008-04-02       Impact factor: 2.103

4.  Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism.

Authors:  Q Dong; R Xiang; D Y Zhang; S Qin
Journal:  Braz J Med Biol Res       Date:  2013-09-19       Impact factor: 2.590

5.  Effects of serum lipid smoothness on the progression and vulnerability of atherosclerotic plaques in rabbits.

Authors:  Xiao Zou; Haijun Wang; Lili Cai; Kailiang Li; Wei Zhang; Yu Ding; Quanjin Si
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

Review 6.  The Scavenger Receptor SREC-I Cooperates with Toll-Like Receptors to Trigger Inflammatory Innate Immune Responses.

Authors:  Ayesha Murshid; Thiago J Borges; Benjamin J Lang; Stuart K Calderwood
Journal:  Front Immunol       Date:  2016-06-13       Impact factor: 7.561

Review 7.  SCARF1: a multifaceted, yet largely understudied, scavenger receptor.

Authors:  Daniel A Patten
Journal:  Inflamm Res       Date:  2018-05-03       Impact factor: 4.575

8.  SCARF-1 promotes adhesion of CD4+ T cells to human hepatic sinusoidal endothelium under conditions of shear stress.

Authors:  Daniel A Patten; Sivesh K Kamarajah; Joanne M Rose; Joseph Tickle; Emma L Shepherd; David H Adams; Chris J Weston; Shishir Shetty
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.